TIL
Instil Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.58
−1.04%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-28.2%
Return on equity
-15.3%
Return on assets
-32.6%
Return on invested capital
0.00x
Asset turnover
-$23.6M
Cash from operations
$10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026